Aspen Pharmacare Stock Price, News & Analysis (JSE:APN)

$27,065.00 -10.00 (-0.04 %)
(As of 02/25/2018 03:03 PM ET)
Previous Close$27,065.00
Today's Range$26,875.00 - $27,392.00
52-Week Range$23,498.00 - $32,750.00
Volume1.18 million shs
Average Volume2.04 million shs
Market Capitalization$123.54 billion
P/E Ratio2,423.01
Dividend Yield1.06%
BetaN/A

About Aspen Pharmacare (JSE:APN)

Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business includes operating subsidiaries in Europe, Commonwealth of Independent States (CIS), Latin America, the Middle East and North Africa, Canada, as well as Mauritius-based Aspen Global Incorporated. The South African business provides branded, generic, over-the-counter, consumer health and infant nutritional products, which are supplied to pharmacies, retail pharmacy chains, hospitals, clinics, prescribing specialists, dispensing general practitioners, managed healthcare funders and retail stores across the private and public sectors in South Africa. Its business in Asia Pacific includes operations in Australasia, the Philippines, Taiwan and Japan.

Receive APN News and Ratings via Email

Sign-up to receive the latest news and ratings for APN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolJSE:APN
CUSIPN/A
Phone+27-11-2396100

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio2423.00805729633
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS$11.17
Net IncomeN/A
Net Margins10.75%
Return on Equity11.09%
Return on Assets4.09%

Miscellaneous

EmployeesN/A
Outstanding Shares455,950,000

Aspen Pharmacare (JSE:APN) Frequently Asked Questions

What is Aspen Pharmacare's stock symbol?

Aspen Pharmacare trades on the JSE under the ticker symbol "APN."

Who are Aspen Pharmacare's key executives?

Aspen Pharmacare's management team includes the folowing people:

  • Stephen Bradley Saad, Group Chief Executive, Executive Director (Age 53)
  • Michael Guy Attridge, Deputy Group Chief Executive, Executive Director (Age 56)
  • Riaan Verster, Company Secretary & Group Governance Officer (Age 41)
  • Kuseni Douglas Dlamini, Non-Executive Chairman of the Board (Age 49)
  • Roy Cecil Andersen CPA, Lead Independent Non-Executive Director (Age 69)
  • Christopher Nattle Mortimer, Non-Executive Director (Age 56)
  • David Redfern, Non-Executive Director (Age 51)
  • John Frederick Buchanan, Non-Executive Independent Director (Age 72)

How do I buy Aspen Pharmacare stock?

Shares of Aspen Pharmacare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Aspen Pharmacare's stock price today?

One share of Aspen Pharmacare stock can currently be purchased for approximately $27,065.00.

How big of a company is Aspen Pharmacare?

Aspen Pharmacare has a market capitalization of $123.54 billion.

How can I contact Aspen Pharmacare?

Aspen Pharmacare's mailing address is Woodmead, JOHANNESBURG, 2194, South Africa. The company can be reached via phone at +27-11-2396100.


MarketBeat Community Rating for Aspen Pharmacare (APN)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  7 (Vote Outperform)
Underperform Votes:  9 (Vote Underperform)
Total Votes:  16
MarketBeat's community ratings are surveys of what our community members think about Aspen Pharmacare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Aspen Pharmacare (JSE:APN) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

Earnings History for Aspen Pharmacare (JSE:APN)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Aspen Pharmacare (JSE:APN) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Aspen Pharmacare (JSE:APN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Aspen Pharmacare (JSE APN) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Aspen Pharmacare (JSE:APN)

Aspen Pharmacare (JSE APN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2018Jeremy YaseniukDirectorSell25,000$0.51$12,750.00
1/26/2018Jeremy YaseniukDirectorBuy10,000$0.41$4,100.00
1/23/2018Jeremy YaseniukDirectorSell50,000$0.49$24,500.00
1/16/2018John WilliamsonInsiderSell25,000$0.45$11,250.00
1/12/2018John WilliamsonInsiderSell20,000$0.48$9,600.00
12/4/2017Justin BourassaInsiderBuy36,000$0.18$6,480.00
11/29/2017John WilliamsonInsiderBuy33,500$0.21$7,035.00
11/23/2017John WilliamsonInsiderSell500,000$0.20$100,000.00
11/14/2017John WilliamsonInsiderBuy75,000$0.18$13,500.00
(Data available from 1/1/2013 forward)

Headlines

Aspen Pharmacare (JSE APN) News Headlines

Source:

SEC Filings

Aspen Pharmacare (JSE:APN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Aspen Pharmacare (JSE APN) Stock Chart for Sunday, February, 25, 2018

Loading chart…

This page was last updated on 2/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.